Cargando…
Valsartan recall: global regulatory overview and future challenges
Autores principales: | Farrukh, Muhammad Junaid, Tariq, Muhammad Haseeb, Malik, Obaidullah, Khan, Tahir Mehmood |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351967/ https://www.ncbi.nlm.nih.gov/pubmed/30728946 http://dx.doi.org/10.1177/2042098618823458 |
Ejemplares similares
-
Bicarbonate Therapy in Renally Compromised Critically Ill Patients with Metabolic Acidosis: Study of Clinical Outcomes and Mortality Rate
por: Rafique, Zakia, et al.
Publicado: (2021) -
Impact of national valsartan recalls on Veterans’ outcomes
por: Morizio, Paige L., et al.
Publicado: (2021) -
Evaluation of clinical manifestations, health risks, and quality of life among women with polycystic ovary syndrome
por: Sidra, Syeda, et al.
Publicado: (2019) -
Understanding the molecular–pharmaceutical basis of sartan recalls focusing on valsartan
por: Ray, Avik, et al.
Publicado: (2020) -
Rational use of antibiotics in an intensive care unit: a retrospective study of the impact on clinical outcomes and mortality rate
por: Ali, Muhammad, et al.
Publicado: (2019)